Prevention studies next big test for Alzheimer’s research
A study set to read out early next year could be the final curtain for an Alzheimer’s disease hypothesis that
BioPharm America™ 2019
12th Annual International Partnering Conference September 11–12, 2019 Boston, MA, USA Boston Convention and Exhibition Center (BCEC) 415 Summer Street,
Driving Sci-tech Growth in the UK Regions
The UK has a long-standing reputation as a world leader in the research and development of new medicines and for
Betting on the Bug: How the Microbiome Can Improve Reproducibility and Translatability
Investigators continually seek to improve the reproducibility of their results and the translatability of their preclinical work, while recognising that
Key Challenges and Potential Solutions for Optimising Downstream Bioprocessing Production
The term “optimise” is often applied to complex manufacturing, automation and business processes and implies that the most efficient function
Gene Therapy: Bubble Boy and Beyond
Gene therapy, which is the delivery of DNA or RNA into cells to treat disease, is at the cutting edge
Changing State of Clinical Trials in the Digital Era
The life sciences industry is undergoing a fundamental change in its business model. The shifts from blockbuster drug to precision
A Statistical Approach to Improve Compound Screening in Cell Culture Media
The Chinese hamster ovary (CHO) cell line is widely used to produce recombinant proteins due to its high growth capacity
Importance of the Quality System: Production, Quality Control & Quality Assurance
An effective quality system is the most important aspect of manufacturing any biological or pharmaceutical product. If the system does
Rapid Host Cell Protein (HCP) Detection with Advanced Trapped Ion Mobility Spectrometry (TIMS) Technology
During biotherapeutic manufacturing, process-related impurities derived from the host organism can contaminate drug products. These contaminants may significantly affect drug
Enhancing Cell Line Development and Streamlining Processes through Single-cell Technology
The field of biological medicines is an exciting and rapidly changing area of drug development. Many existing biological drugs have
How to Gain the Greatest Blockchain Value for Your Business
To say that business is “undergoing significant change” in the 21st century does not do justice to the chaotic upheaval
Connected Labelling: The Holy Grail that Continues to Elude Life Sciences?
If there is one content management challenge that is causing compliance headaches for international life sciences organisations, it is labelling.
The FDA is Shifting Focus to Both Ends of the Product Development Spectrum
The Food and Drug Administration (FDA) recently announced measures it plans to take in order to process and approve progressively
Innovations in Cold Chain Technology
Patient safety will always be the top priority of every clinical trial. Therefore, it is vital that the investigational medicine
BioForward: The ‘Roadmap for Growth’ Life Sciences Event
BioForward, ‘The Roadmap for Growth’ Life Sciences Event, is taking place from 8:00 – 18:00 on Friday 11 October 2019 in the
Stem Cell Community Day 2019
Bringing the global stem cell research community together on November 21 in Lisbon, Portugal Following up on two successful events
Eppendorf
Eppendorf is a leading life science company that develops and sells instruments, consumables, and services for liquid-, sample-, and cell
SMi’s 10th Annual Biosimilars Conference
Conference: Wednesday 25 and Thursday 26 September 2019 Workshop: Tuesday 24th September 2019 Location: Copthorne Tara Hotel, London, UK Website:
Cancer cells are quick-change artists adapting to their environment
Until now, researchers have assumed that the growth of solid tumors originates from cancer stem cells characterized by specific surface
Biobanking 2019
Event Venue & Address: Copthorne Tara Hotel, Scarsdale Place, Kensington, London, UK Event Date: 25-26 September 2019 Organizer Name: SMi
Non-clinical Evaluations for Anti-cancer Drugs with ICH S9 Guideline Q&A – What the Industry Needs to Know
The ICH S9 Guideline Q&A document – published in June 2018 – is designed to clarify some of the most
Raising Organisational Fluency in Real-world Evidence
The planet is currently experiencing global healthcare crises that affect huge populations. From diabetes to Alzheimer’s to mental health conditions,
Applying Standardised NMR Spectroscopy to Research Human Diseases
In this article Professor Matthias Nauck of Universitätsmedizin Greifswald and Roland Leiminger of Bruker BioSpin examine the importance of Biobanks
Alzheimer’s Disease: The Way Forward
Emily Burke at Biotech Primer examines Alzheimer’s disease (AD) and how it ranks as one of the toughest nuts to
Artificial Intelligence Expands the Destiny of DNA Analysis
DNA is the code that has defined humanity for millennia. Until more recently, DNA has determined destiny. There was no
Diagnosis Still Poses the Biggest Challenge in the AIDS Battle
Significant progress has been made in the AIDS response since 1988, however ensuring a swift and accurate diagnosis accessible to
Clinical and Investigator-initiated Trials’ Effect on MSL Responsibilities
Among the many responsibilities assigned to medical science liaisons (MSLs) is facilitating company collaboration with thought leaders on clinical trial
Antibodies Exploration Thanks to Label-free Surface Plasmon Resonance Imaging Technology
Surface plasmon resonance imaging allows the study of molecules binding in label-free and real-time conditions. The power of the technique